Throughout this medical market research, the publisher analyzed 40 cardiac surgery companies in Europe and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this MedSuite report contains all of EU Cardiac Surgery Device market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes an cardiac surgery procedure volume analysis which can also be purchased as a separate report, MedPro.
Markets Covered
EU Cardiac Surgery Device Market Insights
Minimally invasive heart valve therapies, such as TMVr and TAVI, have driven substantial growth in the total European cardiac surgery market. Companies such as Edwards Lifesciences, Medtronic, Abbott and Boston Scientific are all investing in studies and trials to show that their devices are an effective and safe alternative to open-heart surgery. As of 2019, TAVI devices began receiving CE mark approval for use on low-surgical risk patients, with some models projecting the patient pool increasing by as much as 50%.
Abbott led the total European cardiac surgery device market by 2020. The company was strongest in the rapidly expanding transcatheter mitral valve repair (TMVr) market. The MitraClip® transcatheter mitral valve repair system generated nearly half of its overall revenue for 2019.
Overall, the European cardiac surgery device market was valued at €2.6 billion in 2020, with over 50,000 Transcatheter Aortic Valve Implantation (TAVI) procedures performed. Despite COVID19, the market value is expected to reach €5.6 billion in 2026.
Report Regional Coverage
Throughout this research series, the publisher has covered several countries in great detail. The countries covered are:
While this MedSuite report contains all of EU Cardiac Surgery Device market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes an cardiac surgery procedure volume analysis which can also be purchased as a separate report, MedPro.
Markets Covered
- Procedure Volumes for Cardiac Surgery Market in Europe - MedPro
- Tissue Heart Valve Market - MedCore
- Mechanical Heart Valve Market - MedCore
- Transcatheter Mitral Valve Repair Device Market - MedCore
- Transcatheter Heart Valve Replacement Market - MedCore
- On-Pump Coronary Artery Bypass Device Market - MedCore
- Off-Pump Coronary Artery Bypass Device Market - MedCore
- Autotransfusion Device Market - MedCore
- Endoscopic Vessel Harvesting Device Market - MedCore
- Anastomosis Assist Device (AAD) Market - MedCore
- Ventricular Assist Device (VAD) Market - MedCore
- Intra-Aortic Balloon Pump Market - MedCore
- Artificial Heart Device Market - MedCore
- Patent Foramen Ovale Closure Device Market - MedCore
- Atrial Septal & Ventricular Septal Defect Closure Device Market - MedCore
- Left Atrial Appendage Closure Device Market - MedCore
- Preshaped Guidewire Market - MedCore
- Cerebral Embolic Protection Device Market - Appendix
- Balloon Valvuloplasty Market - Appendix
- Transmyocardial Revascularization (TMR) Device Market - Appendix
EU Cardiac Surgery Device Market Insights
Minimally invasive heart valve therapies, such as TMVr and TAVI, have driven substantial growth in the total European cardiac surgery market. Companies such as Edwards Lifesciences, Medtronic, Abbott and Boston Scientific are all investing in studies and trials to show that their devices are an effective and safe alternative to open-heart surgery. As of 2019, TAVI devices began receiving CE mark approval for use on low-surgical risk patients, with some models projecting the patient pool increasing by as much as 50%.
Abbott led the total European cardiac surgery device market by 2020. The company was strongest in the rapidly expanding transcatheter mitral valve repair (TMVr) market. The MitraClip® transcatheter mitral valve repair system generated nearly half of its overall revenue for 2019.
Overall, the European cardiac surgery device market was valued at €2.6 billion in 2020, with over 50,000 Transcatheter Aortic Valve Implantation (TAVI) procedures performed. Despite COVID19, the market value is expected to reach €5.6 billion in 2026.
Report Regional Coverage
Throughout this research series, the publisher has covered several countries in great detail. The countries covered are:
- Germany
- France
- U.K.
- Italy
- Spain
- Benelux (Belgium, Netherlands, and Luxembourg)
- Scandinavia (Denmark, Finland, Norway, and Sweden)
- Switzerland
- Austria
- Portugal
Table of Contents
TABLE OF CONTENTS
RESEARCH METHODOLOGY
DISEASE OVERVIEW
PRODUCT ASSESSMENT
EUROPEAN CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW
IMPACT OF COVID-19 ON THE EUROPEAN CARDIAC SURGERY AND HEART VALVE DEVICE MARKET
COUNTRY PROFILES
PROCEDURE NUMBERS
TISSUE HEART VALVE MARKET
MECHANICAL HEART VALVE MARKET
ANNULOPLASTY REPAIR DEVICE MARKET
TRANSCATHETER MITRAL VALVE REPAIR DEVICE MARKET
TRANSCATHETER AORTIC VALVE IMPLANTATION DEVICE MARKET
ON-PUMP CORONARY ARTERY BYPASS DEVICE MARKET
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott
- Abiomed
- Atricure
- B. Braun
- Berlin Heart
- Biosense Webster
- BioStable
- Boston Scientific
- Carag
- Cardia
- Cardio Dimensions
- Cardio Medical
- Comed
- Cook Medical
- CryoLife
- Edwards Lifesciences
- Fresenius
- Getinge
- Gore
- Haemonetics
- Jarvik Heart
- JenaValve
- Labcor
- Lepu Medical
- Lifetech Scientific
- LivaNova
- Med Europe
- Medtronic
- Meril Life Sciences
- Nipro
- NVT GmbH
- Occlutech
- Reliant
- Spectrum Medical
- SynCardia
- Teleflex
- Terumo
- Venus Medtech
- Vitalitec
- Zeon Medical Inc
